Cargando…

Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression

IMPORTANCE: Despite a hypothesis that harboring a leucine-rich repeat kinase 2(LRRK2) G2019S variation and a glucocerebrosidase (GBA) variant would have a combined deleterious association with disease pathogenesis, milder clinical phenotypes have been reported in dual LRRK2 and GBA variations Parkin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortega, Roberto A., Wang, Cuiling, Raymond, Deborah, Bryant, Nicole, Scherzer, Clemens R., Thaler, Avner, Alcalay, Roy N., West, Andrew B., Mirelman, Anat, Kuras, Yuliya, Marder, Karen S., Giladi, Nir, Ozelius, Laurie J., Bressman, Susan B., Saunders-Pullman, Rachel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060834/ https://www.ncbi.nlm.nih.gov/pubmed/33881531 http://dx.doi.org/10.1001/jamanetworkopen.2021.5845

Ejemplares similares

Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?
por: Saunders-Pullman, Rachel, et al.
Publicado: (2014)

Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers
por: Thaler, Avner, et al.
Publicado: (2021)

Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
por: San Luciano, Marta, et al.
Publicado: (2017)

Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease
por: Thaler, Avner, et al.
Publicado: (2020)

Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers
por: Droby, Amgad, et al.
Publicado: (2022)

GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder
por: Gan-Or, Ziv, et al.
Publicado: (2015)

Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()()
por: Xu, Yaqian, et al.
Publicado: (2020)

The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews
por: Shiner, Tamara, et al.
Publicado: (2021)

A Personalized Approach to Parkinson’s Disease Patients Based on Founder Mutation Analysis
por: Giladi, Nir, et al.
Publicado: (2016)

Cognitive Functioning of Glucocerebrosidase (GBA) Non-manifesting Carriers
por: Moran, Eileen E., et al.
Publicado: (2021)

Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease
por: Kozlovski, Tal, et al.
Publicado: (2019)

Whole brain and deep gray matter structure segmentation: Quantitative comparison between MPRAGE and MP2RAGE sequences
por: Droby, Amgad, et al.
Publicado: (2021)

Overnight Distribution of REM Sleep Features in People with Parkinson’s Disease (PD) and Non-PD Controls
por: Dagay, Andrew, et al.
Publicado: (2023)

The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol
por: Bregman, Noa, et al.
Publicado: (2023)

Correction: The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol
por: Bregman, Noa, et al.
Publicado: (2023)

Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation
por: Shkury, Eden, et al.
Publicado: (2023)

Effects of Aging on Arm Swing during Gait: The Role of Gait Speed and Dual Tasking
por: Mirelman, Anat, et al.
Publicado: (2015)

C9orf72-G(4)C(2) Intermediate Repeats and Parkinson’s Disease; A Data-Driven Hypothesis
por: Kobo, Hila, et al.
Publicado: (2021)

Imaging Markers in Genetic Forms of Parkinson’s Disease
por: Droby, Amgad, et al.
Publicado: (2023)

Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease
por: Lai, Dongbing, et al.
Publicado: (2021)

Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use?
por: Roopnarain, Karisha, et al.
Publicado: (2023)

LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
por: Pang, Shirley Yin-Yu, et al.
Publicado: (2022)

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts
por: Merchant, Kalpana M., et al.
Publicado: (2023)

R869C mutation in molecular motor KIF17 gene is involved in dementia with Lewy bodies
por: Goldstein, Orly, et al.
Publicado: (2021)

Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease
por: Surface, Matthew, et al.
Publicado: (2021)

Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
por: Smith, Laura J., et al.
Publicado: (2022)

Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
por: Volta, Mattia
Publicado: (2022)

GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy
por: Huh, Young Eun, et al.
Publicado: (2023)

Novel Variants in LRRK2 and GBA Identified in Latino Parkinson Disease Cohort Enriched for Caribbean Origin
por: Nuytemans, Karen, et al.
Publicado: (2020)

Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson’s Disease
por: San Luciano, Marta, et al.
Publicado: (2016)

Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity
por: Omer, Nurit, et al.
Publicado: (2021)

Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
por: Ben Bashat, Dafna, et al.
Publicado: (2022)

Perspective on the current state of the LRRK2 field
por: Taymans, Jean-Marc, et al.
Publicado: (2023)

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial
por: Peterschmitt, M. Judith, et al.
Publicado: (2022)

SPARC: a new approach to quantifying gait smoothness in patients with Parkinson’s disease
por: Beck, Yoav, et al.
Publicado: (2018)

A novel performance scoring quantification framework for stress test set-ups
por: Kozlovski, Tal, et al.
Publicado: (2023)

A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
por: von Linstow, Christian U., et al.
Publicado: (2020)

Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
por: Tang, Yuting, et al.
Publicado: (2023)

Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study
por: O'Bryant, Sid E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7r02atf1p4vh39d05k9hm20740